Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo

July 29, 2026 8:13 AM

Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $72.00 (from $48.00) while maintaining a Overweight rating.

No results found